Drug Type Small molecule drug |
Synonyms ECP-1014, GIBH-1014 |
Target |
Action inhibitors |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 1 | China | 01 May 2023 | |
Non-Small Cell Lung Cancer | Phase 1 | China | 01 May 2023 | |
Inflammation | Preclinical | United States | - | |
Inflammation | Preclinical | China | - | |
Neoplasms | Preclinical | China | - | |
Pain | Preclinical | United States | - | |
Pain | Preclinical | China | - |